CN111074010A - 一种新的快速检测2019-nCoV核酸试剂盒及应用 - Google Patents
一种新的快速检测2019-nCoV核酸试剂盒及应用 Download PDFInfo
- Publication number
- CN111074010A CN111074010A CN202010162069.XA CN202010162069A CN111074010A CN 111074010 A CN111074010 A CN 111074010A CN 202010162069 A CN202010162069 A CN 202010162069A CN 111074010 A CN111074010 A CN 111074010A
- Authority
- CN
- China
- Prior art keywords
- primer
- ncov
- seq
- nucleic acid
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 23
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 23
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 23
- 241001678559 COVID-19 virus Species 0.000 title claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 44
- 238000006243 chemical reaction Methods 0.000 claims abstract description 29
- 238000011529 RT qPCR Methods 0.000 claims description 19
- 239000002773 nucleotide Substances 0.000 claims description 18
- 125000003729 nucleotide group Chemical group 0.000 claims description 18
- 238000010839 reverse transcription Methods 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 238000004090 dissolution Methods 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- 239000013641 positive control Substances 0.000 claims description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 239000013642 negative control Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 239000007850 fluorescent dye Substances 0.000 claims description 4
- 102100034343 Integrase Human genes 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 230000003321 amplification Effects 0.000 abstract description 14
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 14
- 241000700605 Viruses Species 0.000 abstract description 13
- 230000008018 melting Effects 0.000 abstract description 10
- 238000002844 melting Methods 0.000 abstract description 10
- 239000000523 sample Substances 0.000 abstract description 8
- 230000007062 hydrolysis Effects 0.000 abstract description 5
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 5
- 244000052769 pathogen Species 0.000 abstract description 4
- 238000004458 analytical method Methods 0.000 abstract description 3
- 238000004451 qualitative analysis Methods 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 15
- 238000012360 testing method Methods 0.000 description 9
- 241000112286 Bat SARS-like coronavirus Species 0.000 description 8
- 241000112287 Bat coronavirus Species 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 230000000241 respiratory effect Effects 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 241000711573 Coronaviridae Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 208000001528 Coronaviridae Infections Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002247 constant time method Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 241000124740 Bocaparvovirus Species 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 208000027691 Conduct disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000711467 Human coronavirus 229E Species 0.000 description 1
- 241000482741 Human coronavirus NL63 Species 0.000 description 1
- 241001428935 Human coronavirus OC43 Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000713196 Influenza B virus Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000351643 Metapneumovirus Species 0.000 description 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000011157 hong shi Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 208000026425 severe pneumonia Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010162069.XA CN111074010B (zh) | 2020-03-10 | 2020-03-10 | 一种快速检测2019-nCoV核酸试剂盒及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010162069.XA CN111074010B (zh) | 2020-03-10 | 2020-03-10 | 一种快速检测2019-nCoV核酸试剂盒及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111074010A true CN111074010A (zh) | 2020-04-28 |
CN111074010B CN111074010B (zh) | 2020-11-13 |
Family
ID=70324645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010162069.XA Active CN111074010B (zh) | 2020-03-10 | 2020-03-10 | 一种快速检测2019-nCoV核酸试剂盒及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111074010B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111304372A (zh) * | 2020-04-29 | 2020-06-19 | 圣湘生物科技股份有限公司 | 检测2019新型冠状病毒突变的组合物、用途及试剂盒 |
CN111413496A (zh) * | 2020-05-18 | 2020-07-14 | 博奥赛斯(天津)生物科技有限公司 | 一种新型冠状病毒IgM/IgG抗体化学发光法检测试剂盒 |
WO2022040355A3 (en) * | 2020-08-19 | 2022-03-31 | City Of Hope | Lamp detection of sars-cov-2 in saliva for the rapid diagnosis of covid-19 |
-
2020
- 2020-03-10 CN CN202010162069.XA patent/CN111074010B/zh active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111304372A (zh) * | 2020-04-29 | 2020-06-19 | 圣湘生物科技股份有限公司 | 检测2019新型冠状病毒突变的组合物、用途及试剂盒 |
CN111304372B (zh) * | 2020-04-29 | 2020-08-14 | 圣湘生物科技股份有限公司 | 检测2019新型冠状病毒突变的组合物、用途及试剂盒 |
CN111413496A (zh) * | 2020-05-18 | 2020-07-14 | 博奥赛斯(天津)生物科技有限公司 | 一种新型冠状病毒IgM/IgG抗体化学发光法检测试剂盒 |
CN111413496B (zh) * | 2020-05-18 | 2023-05-05 | 天津博奥赛斯生物科技股份有限公司 | 一种新型冠状病毒IgM/IgG抗体化学发光法检测试剂盒 |
WO2022040355A3 (en) * | 2020-08-19 | 2022-03-31 | City Of Hope | Lamp detection of sars-cov-2 in saliva for the rapid diagnosis of covid-19 |
Also Published As
Publication number | Publication date |
---|---|
CN111074010B (zh) | 2020-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111020064B (zh) | 新型冠状病毒ORF1ab基因核酸检测试剂盒 | |
Zhang et al. | A protocol for detection of COVID-19 using CRISPR diagnostics | |
CN111004870B (zh) | 新型冠状病毒n基因核酸检测试剂盒 | |
CN111254228B (zh) | 一种检测新型冠状病毒和流感病毒的试剂盒 | |
CN111074010B (zh) | 一种快速检测2019-nCoV核酸试剂盒及应用 | |
CN105695634B (zh) | 检测非洲猪瘟病毒的pcr引物、试剂盒及其应用 | |
BR112014000138B1 (pt) | Método para identificar a presença ou ausência de um ácido nucleico alvo | |
JP2012080884A (ja) | 核酸検出 | |
CN113930547A (zh) | 猪流行性腹泻病毒n基因的rt-raa荧光法检测引物对、试剂盒及检测方法 | |
CN111808988A (zh) | 一种covid-19核酸释放剂及核酸检测试剂盒 | |
CN115461476A (zh) | 用于检测SARS-CoV-2新型冠状病毒的引物及其试剂盒、检测方法和应用 | |
CN117210586A (zh) | 检测9种呼吸道感染病原菌的引物探针组合、试剂盒及其应用 | |
CN103966356A (zh) | 人类免疫缺陷病毒1型一步法荧光定量pcr检测试剂盒 | |
KR20230007464A (ko) | 호흡기 병원체 검출을 위한 검체수송 키트 및 이를 이용한 호흡기 병원체 검출방법 | |
CN104342487B (zh) | 支原体核酸恒温扩增方法 | |
CN111074009B (zh) | 一种快速检测2019-nCoV复制试剂盒及应用 | |
JP2012143185A (ja) | 口蹄疫ウィルスの包括的検出方法 | |
CN116121439A (zh) | 一种多重定量pcr检测真菌的方法以及试剂盒 | |
RU2762236C1 (ru) | Набор синтетических олигонуклеотидных праймеров для получения полной нуклеотидной последовательности гена vp1 энтеровируса коксаки а10 | |
CN111549175B (zh) | 一种检测口岸输入2019新型冠状病毒多重荧光rt-pcr检测试剂 | |
CN114480726A (zh) | 非洲猪瘟病毒核酸检测的引物探针组、试剂盒及检测方法 | |
CN112662811A (zh) | 一种新型冠状病毒4基因区段多重核酸检测试剂盒及其应用 | |
CN111996288A (zh) | 检测冠状病毒的组合物、试剂盒和方法 | |
CN108949954A (zh) | 用于检测慢性鼻窦炎伴鼻息肉亚型的试剂盒及alox15基因作为生物标志物的应用 | |
CN114381458B (zh) | 基于液滴pcr的东方恙虫定量检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A rapid detection kit for 2019 ncov nucleic acid and its application Effective date of registration: 20211214 Granted publication date: 20201113 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20201113 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |